CAR T-Cell Therapy for Relapsed/Refractory CLL
2 Ansichten
• 07/14/23
0
0
Einbetten
administrator
Abonnenten
The panelists provide insight on the use of chimeric antigen receptor T-cell therapy for chronic lymphocytic leukemia and the TRANSCEND CLL-004 trial of liso-cel (JCAR017) in relapsed/refractory disease.
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare